TPO and autoimmune thrombocytopenic purpura: This paper aims to review the current TPO-RAs approved for primary ITP (romiplostim, eltrombopag, avatrombopag) and the effect of intermittent fasting in adult patients with primary ITP receiving TPO-RAs.